Singh et al. reported lower circulating IL-33 and higher levels of soluble ST2 (sST2) in T2D patients compared to healthy individuals, with IL-33 negatively correlating with glycemia, implying a protective metabolic role [46]. This evidence concerns the gene IL33 and type 2 diabetes mellitus.